Results for systolic b/p translation from English to Italian

b p<0.0001
b p < 0,0001

b p < 0.05 p = ns
b p < 0,05 p = ns

hanff frères b. p.
hanff frères b.p.

elendt b. p., (1990).
elendt b. p., (1990).

a p < 0.001 b p < 0.01
a p < 0,001 b p < 0,01

c.ii.1(b) p. 342
c.ii.1, lett. b), pag. 342

b p < 0.001 compared with etanercept
bp < 0,001 rispetto a etanercept

hr (95% ci)b p-valuec
hr (ci 95%)b valore pc

b: p = 0.002, enbrel vs. placebo
b: p = 0,002, enbrel vs placebo

method a b = p – d – n – s
metodo a b = p – d – n – s

adjusted rate b p<0.001, humira vs. placebo
calcolata sotto forma di center-adjusted rate b p<0,001, humira vs. placebo

b p < 0.05. c not applicable. d p < 0.001.
b p < 0,05. c non pertinente. d p < 0,001.

b p < 0.05 c nominally significant (p < 0.05)
b p < 0,05 c nominalmente significativa (p < 0,05)

comparison versus placebo: a p<0.001; b p<0.01
confronti con placebo: a p<0,001; b p<0,01

bristol-myers squibb la goualle b. p.6 19250 meymac france
bristol-myers squibb la goualle b. p.6 19250 meymac francia

patients who attempted to reduce or discontinue baseline therapy, n (%)b p-value a
pazienti che hanno tentato di ridurre o interrompere la terapia di base, n (%)b valore-p a

b p < 0.001, etanercept vs. placebo c p < 0.01, etanercept vs. placebo
a p < 0,001, etanercept vs. placebo b p = 0,002, etanercept vs. placebo

a: p 0.001, enbrel vs.placebo b: p = 0.002, enbrel vs. placebo
a: p 0,001, enbrel vs placebo b: p = 0,002, enbrel vs placebo

a p < 0.001; b p = 0.010; c p = 0.009; d p = 0.014
a p < 0,001; b p = 0,010; c p = 0,009; d p = 0,014

partenaires: b, p, uk, autriche, slovénie participation: b, p, uk, autriche, slovénie
partners: b, p, uk, austria, repubblica slovacca partecipazione: b, p, uk, austria, repubblica slovacca